Frontiers in Peptide Science and Drug Discovery Symposium
The symposium in honour of Professor James Tam will take place on 5 August 2022 at the School of Biological Sciences Classroom 1, Nanyang Technological University (NTU), Singapore.
Professor James Tam is the Founding Dean of the School of Biological Sciences (SBS), the Founding Director of the Biological Research Center and the Founding Director of the double-degree program in Biomedical Science and Chinese Medicine at NTU. He is currently the Lee Wee Nam Professor and the Director of the Synzymes and Natural Products Center in SBS.
He invented peptide dendrimers as protein mimetics in the 1980s for immunologics. His recent research work focuses on the discovery, design and development of bio-therapeutics for healthy ageing, particularly ultra-stable, orally-active peptide biologics from medicinal plants.
The symposium is jointly organised by the School of Biological Sciences and the NTU-Institute of Advanced Studies (NTU-IAS) in honour of Professor Tam's outstanding research works and lifetime achievements in Peptide Science and Drug Discovery. It will cover many exciting fields of peptide and protein research including chemistry, structure and function, and applications in medicine and materials science.
We hope that this symposium would provide a platform for our participants to present and learn about the current forefront of peptide / protein science and drug discovery; as well as to exchange ideas and establish research collaborations or business relations across both academia and industry.
Symposium Chair, School of Biological Sciences, NTU Singapore
Our Distinguished Speakers
-chen3d08ef4b-ee21-423e-b8f5-6ec959c6b82d.tmb-thumb200.jpg?Culture=en&sfvrsn=ddad30d2_1)


Yoshio Hayashi
Tokyo University of Pharmacy and Life Sciences, Japan
A New Synthetic Chemistry of Cyclic Peptides for the Development of Mid-sized Peptide Drugs

Hironobu Hojo
Osaka University, Japan
Synthesis of Selenocysteine-containing Proteins and their Properties

Kimberly Kline
University of Geneva, Switzerland
Targeting Both Host and Bacteria to Overcome Vancomycin Resistance in Enterococcus faecalis

Kit Lam
UC Davis Medical School, USA
From Combinatorial Chemistry to Nanotheranostic Agents Against Cancer



Joshua Mylne
Curtin University, Australia

Hirokazu Tamamura
Tokyo Medical and Dental University (TMDU), Japan
From HIV to SARS-CoV-2: Fusion Inhibitors Based on Dimerization of HR2 Region Peptides

Xiaoliang Wang
Institute of Meteria Medica, Chinese Academy of Medical Sciences, China
Development of Novel Drug from Nature product l-3-butylphalide for treatment of Ischemic Stroke and Dementia